Publications by authors named "Eva Erdmann"

Claim this Profile
H
Human-specific genomic evolution of a regulatory network enables fine-tuning of N-cadherin gene expression.
Éva Erdmann, Savera Agolli, Simon Fix, Félicie Cottard, Christine Keyser

Cell Mol Life Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Androgen receptor-mediated transcriptional repression targets cell plasticity in prostate cancer.
Éva Erdmann, Pauline Ould Madi Berthélémy, Félicie Cottard, Charlotte Zoe Angel, Edwige Schreyer

Mol Oncol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorine NMR study of proline-rich sequences using fluoroprolines.
Davy Sinnaeve, Abir Ben Bouzayene, Emile Ottoy, Gert-Jan Hofman, Eva Erdmann

Magn Reson (Gott)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder.
Raphael Carapito, Ekaterina L Ivanova, Aurore Morlon, Linyan Meng, Anne Molitor, Eva Erdmann

Am J Hum Genet· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder.
Raphael Carapito, Ekaterina L Ivanova, Aurore Morlon, Linyan Meng, Anne Molitor, Eva Erdmann

Am J Hum Genet· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual effects of constitutively active androgen receptor and full-length androgen receptor for N-cadherin regulation in prostate cancer.
Félicie Cottard, Pauline Ould Madi-Berthélémy, Eva Erdmann, Frédérique Schaff-Wendling, Céline Keime

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutively active androgen receptor variants upregulate expression of mesenchymal markers in prostate cancer cells.
Félicie Cottard, Irène Asmane, Eva Erdmann, Jean-Pierre Bergerat, Jean-Emmanuel Kurtz

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of hormone escape in a human prostate cancer model depends on therapy modalities and can be reduced by tyrosine kinase inhibitors.
Charlotte Guyader, Jocelyn Céraline, Eléonore Gravier, Aurélie Morin, Sandrine Michel, Eva Erdmann

PLoS One· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.
Gemma Marcias, Eva Erdmann, Gaëlle Lapouge, Christelle Siebert, Philippe Barthélémy

Hum Mutat· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific properties of a C-terminal truncated androgen receptor detected in hormone refractory prostate cancer.
Gaëlle Lapouge, Gemma Marcias, Eva Erdmann, Pascal Kessler, Marion Cruchant

Adv Exp Med Biol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation--a new paradigm for cooperation among prostate tumor cells.
Gaëlle Lapouge, Eva Erdmann, Gemma Marcias, Monika Jagla, Audrey Monge

Int J Cancer· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions.
Monika Jagla, Marie Fève, Pascal Kessler, Gaëlle Lapouge, Eva Erdmann

Endocrinology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.
Jocelyn Céraline, Marion D Cruchant, Eva Erdmann, Philippe Erbs, Jean-Emmanuel Kurtz

Int J Cancer· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer.
Jocelyn Céraline, Eva Erdmann, Philippe Erbs, Marion Deslandres-Cruchant, Didier Jacqmin

Eur J Endocrinol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis